Smart Blood Glucose Monitors
The research report includes specific segments by region (country), by company, by Type and by Ap ... Read More
Global Pet Vaccine Market Research Report 2023
1 Pet Vaccine Market Overview
1.1 Product Overview and Scope of Pet Vaccine
1.2 Pet Vaccine Segment by Type
1.2.1 Global Pet Vaccine Sales Growth Rate Comparison by Type (2022-2028)
1.2.2 Attenuated Live Vaccines
1.2.3 Conjugate Vaccines
1.2.4 Inactivated Vaccines
1.2.5 Subunit Vaccines
1.2.6 Toxoid Vaccines
1.2.7 DNA Vaccines
1.2.8 Recombinant Vaccines
1.3 Pet Vaccine Segment by Application
1.3.1 Global Pet Vaccine Sales Comparison by Application: (2022-2028)
1.3.2 Canine
1.3.3 Avian
1.3.4 Feline
1.4 Global Pet Vaccine Market Size Estimates and Forecasts
1.4.1 Global Pet Vaccine Revenue 2017-2028
1.4.2 Global Pet Vaccine Sales 2017-2028
1.4.3 Pet Vaccine Market Size by Region: 2017 Versus 2021 Versus 2028
2 Pet Vaccine Market Competition by Manufacturers
2.1 Global Pet Vaccine Sales Market Share by Manufacturers (2017-2022)
2.2 Global Pet Vaccine Revenue Market Share by Manufacturers (2017-2022)
2.3 Global Pet Vaccine Average Price by Manufacturers (2017-2022)
2.4 Manufacturers Pet Vaccine Manufacturing Sites, Area Served, Product Type
2.5 Pet Vaccine Market Competitive Situation and Trends
2.5.1 Pet Vaccine Market Concentration Rate
2.5.2 The Global Top 5 and Top 10 Largest Pet Vaccine Players Market Share by Revenue
2.5.3 Global Pet Vaccine Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.6 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Pet Vaccine Retrospective Market Scenario by Region
3.1 Global Pet Vaccine Retrospective Market Scenario in Sales by Region: 2017-2022
3.2 Global Pet Vaccine Retrospective Market Scenario in Revenue by Region: 2017-2022
3.3 North America Pet Vaccine Market Facts & Figures by Country
3.3.1 North America Pet Vaccine Sales by Country
3.3.2 North America Pet Vaccine Revenue by Country
3.3.3 U.S.
3.3.4 Canada
3.4 Europe Pet Vaccine Market Facts & Figures by Country
3.4.1 Europe Pet Vaccine Sales by Country
3.4.2 Europe Pet Vaccine Revenue by Country
3.4.3 Germany
3.4.4 France
3.4.5 U.K.
3.4.6 Italy
3.4.7 Russia
3.5 Asia Pacific Pet Vaccine Market Facts & Figures by Region
3.5.1 Asia Pacific Pet Vaccine Sales by Region
3.5.2 Asia Pacific Pet Vaccine Revenue by Region
3.5.3 China
3.5.4 Japan
3.5.5 South Korea
3.5.6 India
3.5.7 Australia
3.5.8 Taiwan
3.5.9 Indonesia
3.5.10 Thailand
3.5.11 Malaysia
3.5.12 Philippines
3.5.13 Vietnam
3.6 Latin America Pet Vaccine Market Facts & Figures by Country
3.6.1 Latin America Pet Vaccine Sales by Country
3.6.2 Latin America Pet Vaccine Revenue by Country
3.6.3 Mexico
3.6.4 Brazil
3.6.5 Argentina
3.7 Middle East and Africa Pet Vaccine Market Facts & Figures by Country
3.7.1 Middle East and Africa Pet Vaccine Sales by Country
3.7.2 Middle East and Africa Pet Vaccine Revenue by Country
3.7.3 Turkey
3.7.4 Saudi Arabia
3.7.5 U.A.E
4 Global Pet Vaccine Historic Market Analysis by Type
4.1 Global Pet Vaccine Sales Market Share by Type (2017-2022)
4.2 Global Pet Vaccine Revenue Market Share by Type (2017-2022)
4.3 Global Pet Vaccine Price by Type (2017-2022)
5 Global Pet Vaccine Historic Market Analysis by Application
5.1 Global Pet Vaccine Sales Market Share by Application (2017-2022)
5.2 Global Pet Vaccine Revenue Market Share by Application (2017-2022)
5.3 Global Pet Vaccine Price by Application (2017-2022)
6 Key Companies Profiled
6.1 Bayer Healthcare
6.1.1 Bayer Healthcare Corporation Information
6.1.2 Bayer Healthcare Description and Business Overview
6.1.3 Bayer Healthcare Pet Vaccine Sales, Revenue and Gross Margin (2017-2022)
6.1.4 Bayer Healthcare Pet Vaccine Product Portfolio
6.1.5 Bayer Healthcare Recent Developments/Updates
6.2 Vetoquinol S.A
6.2.1 Vetoquinol S.A Corporation Information
6.2.2 Vetoquinol S.A Description and Business Overview
6.2.3 Vetoquinol S.A Pet Vaccine Sales, Revenue and Gross Margin (2017-2022)
6.2.4 Vetoquinol S.A Pet Vaccine Product Portfolio
6.2.5 Vetoquinol S.A Recent Developments/Updates
6.3 Boehringer Ingelheim
6.3.1 Boehringer Ingelheim Corporation Information
6.3.2 Boehringer Ingelheim Description and Business Overview
6.3.3 Boehringer Ingelheim Pet Vaccine Sales, Revenue and Gross Margin (2017-2022)
6.3.4 Boehringer Ingelheim Pet Vaccine Product Portfolio
6.3.5 Boehringer Ingelheim Recent Developments/Updates
6.4 Ceva
6.4.1 Ceva Corporation Information
6.4.2 Ceva Description and Business Overview
6.4.3 Ceva Pet Vaccine Sales, Revenue and Gross Margin (2017-2022)
6.4.4 Ceva Pet Vaccine Product Portfolio
6.4.5 Ceva Recent Developments/Updates
6.5 Eli Lilly
6.5.1 Eli Lilly Corporation Information
6.5.2 Eli Lilly Description and Business Overview
6.5.3 Eli Lilly Pet Vaccine Sales, Revenue and Gross Margin (2017-2022)
6.5.4 Eli Lilly Pet Vaccine Product Portfolio
6.5.5 Eli Lilly Recent Developments/Updates
6.6 Heska Co.
6.6.1 Heska Co. Corporation Information
6.6.2 Heska Co. Description and Business Overview
6.6.3 Heska Co. Pet Vaccine Sales, Revenue and Gross Margin (2017-2022)
6.6.4 Heska Co. Pet Vaccine Product Portfolio
6.6.5 Heska Co. Recent Developments/Updates
6.7 Merck Animal Health
6.6.1 Merck Animal Health Corporation Information
6.6.2 Merck Animal Health Description and Business Overview
6.6.3 Merck Animal Health Pet Vaccine Sales, Revenue and Gross Margin (2017-2022)
6.4.4 Merck Animal Health Pet Vaccine Product Portfolio
6.7.5 Merck Animal Health Recent Developments/Updates
6.8 Merial (Sanofi)
6.8.1 Merial (Sanofi) Corporation Information
6.8.2 Merial (Sanofi) Description and Business Overview
6.8.3 Merial (Sanofi) Pet Vaccine Sales, Revenue and Gross Margin (2017-2022)
6.8.4 Merial (Sanofi) Pet Vaccine Product Portfolio
6.8.5 Merial (Sanofi) Recent Developments/Updates
6.9 Virbac
6.9.1 Virbac Corporation Information
6.9.2 Virbac Description and Business Overview
6.9.3 Virbac Pet Vaccine Sales, Revenue and Gross Margin (2017-2022)
6.9.4 Virbac Pet Vaccine Product Portfolio
6.9.5 Virbac Recent Developments/Updates
6.10 Zoetis (Pfizer)
6.10.1 Zoetis (Pfizer) Corporation Information
6.10.2 Zoetis (Pfizer) Description and Business Overview
6.10.3 Zoetis (Pfizer) Pet Vaccine Sales, Revenue and Gross Margin (2017-2022)
6.10.4 Zoetis (Pfizer) Pet Vaccine Product Portfolio
6.10.5 Zoetis (Pfizer) Recent Developments/Updates
7 Pet Vaccine Manufacturing Cost Analysis
7.1 Pet Vaccine Key Raw Materials Analysis
7.1.1 Key Raw Materials
7.1.2 Key Suppliers of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
7.3 Manufacturing Process Analysis of Pet Vaccine
7.4 Pet Vaccine Industrial Chain Analysis
8 Marketing Channel, Distributors and Customers
8.1 Marketing Channel
8.2 Pet Vaccine Distributors List
8.3 Pet Vaccine Customers
9 Pet Vaccine Market Dynamics
9.1 Pet Vaccine Industry Trends
9.2 Pet Vaccine Market Drivers
9.3 Pet Vaccine Market Challenges
9.4 Pet Vaccine Market Restraints
10 Global Market Forecast
10.1 Pet Vaccine Market Estimates and Projections by Type
10.1.1 Global Forecasted Sales of Pet Vaccine by Type (2023-2028)
10.1.2 Global Forecasted Revenue of Pet Vaccine by Type (2023-2028)
10.2 Pet Vaccine Market Estimates and Projections by Application
10.2.1 Global Forecasted Sales of Pet Vaccine by Application (2023-2028)
10.2.2 Global Forecasted Revenue of Pet Vaccine by Application (2023-2028)
10.3 Pet Vaccine Market Estimates and Projections by Region
10.3.1 Global Forecasted Sales of Pet Vaccine by Region (2023-2028)
10.3.2 Global Forecasted Revenue of Pet Vaccine by Region (2023-2028)
11 Research Finding and Conclusion
12 Methodology and Data Source
12.1 Methodology/Research Approach
12.1.1 Research Programs/Design
12.1.2 Market Size Estimation
12.1.3 Market Breakdown and Data Triangulation
12.2 Data Source
12.2.1 Secondary Sources
12.2.2 Primary Sources
12.3 Author List
12.4 Disclaimer
List of Tables
Table 1. Global Pet Vaccine Sales Growth Rate Comparison by Type (2022-2028) & (K Doses) & (US$ Million)
Table 2. Global Pet Vaccine Sales Growth Rate Comparison by Application (2022-2028) & (K Doses) & (US$ Million)
Table 3. Global Pet Vaccine Market Size by Region (US$ Million) (2017 VS 2021 VS 2028)
Table 4. Global Pet Vaccine Market Competitive Situation by Manufacturers in 2021
Table 5. Global Pet Vaccine Sales (K Doses) of Key Manufacturers (2017-2022)
Table 6. Global Pet Vaccine Sales Market Share by Manufacturers (2017-2022)
Table 7. Global Pet Vaccine Revenue (US$ Million) by Manufacturers (2017-2022)
Table 8. Global Pet Vaccine Revenue Share by Manufacturers (2017-2022)
Table 9. Global Market Pet Vaccine Average Price (USD/Dose) of Key Manufacturers (2017-2022)
Table 10. Manufacturers Pet Vaccine Manufacturing Sites and Area Served
Table 11. Manufacturers Pet Vaccine Product Type
Table 12. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 13. Global Pet Vaccine by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Pet Vaccine as of 2021)
Table 14. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 15. Global Pet Vaccine Sales by Region (2017-2022) & (K Doses)
Table 16. Global Pet Vaccine Sales Market Share by Region (2017-2022)
Table 17. Global Pet Vaccine Revenue by Region (2017-2022) & (US$ Million)
Table 18. Global Pet Vaccine Revenue Market Share by Region (2017-2022)
Table 19. North America Pet Vaccine Sales by Country (2017-2022) & (K Doses)
Table 20. North America Pet Vaccine Sales Market Share by Country (2017-2022)
Table 21. North America Pet Vaccine Revenue by Country (2017-2022) & (US$ Million)
Table 22. North America Pet Vaccine Revenue Market Share by Country (2017-2022)
Table 23. Europe Pet Vaccine Sales by Country (2017-2022) & (K Doses)
Table 24. Europe Pet Vaccine Sales Market Share by Country (2017-2022)
Table 25. Europe Pet Vaccine Revenue by Country (2017-2022) & (US$ Million)
Table 26. Europe Pet Vaccine Revenue Market Share by Country (2017-2022)
Table 27. Asia Pacific Pet Vaccine Sales by Region (2017-2022) & (K Doses)
Table 28. Asia Pacific Pet Vaccine Sales Market Share by Region (2017-2022)
Table 29. Asia Pacific Pet Vaccine Revenue by Region (2017-2022) & (US$ Million)
Table 30. Asia Pacific Pet Vaccine Revenue Market Share by Region (2017-2022)
Table 31. Latin America Pet Vaccine Sales by Country (2017-2022) & (K Doses)
Table 32. Latin America Pet Vaccine Sales Market Share by Country (2017-2022)
Table 33. Latin America Pet Vaccine Revenue by Country (2017-2022) & (US$ Million)
Table 34. Latin America Pet Vaccine Revenue Market Share by Country (2017-2022)
Table 35. Middle East and Africa Pet Vaccine Sales by Country (2017-2022) & (K Doses)
Table 36. Middle East and Africa Pet Vaccine Sales Market Share by Country (2017-2022)
Table 37. Middle East and Africa Pet Vaccine Revenue by Country (2017-2022) & (US$ Million)
Table 38. Middle East and Africa Pet Vaccine Revenue Market Share by Country (2017-2022)
Table 39. Global Pet Vaccine Sales by Type (2017-2022) & (K Doses)
Table 40. Global Pet Vaccine Sales Market Share by Type (2017-2022)
Table 41. Global Pet Vaccine Revenue by Type (2017-2022) & (US$ Million)
Table 42. Global Pet Vaccine Revenue Share by Type (2017-2022)
Table 43. Global Pet Vaccine Price by Type (2017-2022) & (USD/Dose)
Table 44. Global Pet Vaccine Sales (K Doses) by Application (2017-2022)
Table 45. Global Pet Vaccine Sales Market Share by Application (2017-2022)
Table 46. Global Pet Vaccine Revenue by Application (2017-2022) & (US$ Million)
Table 47. Global Pet Vaccine Revenue Share by Application (2017-2022)
Table 48. Global Pet Vaccine Price by Application (2017-2022) & (USD/Dose)
Table 49. Bayer Healthcare Corporation Information
Table 50. Bayer Healthcare Description and Business Overview
Table 51. Bayer Healthcare Pet Vaccine Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2017-2022)
Table 52. Bayer Healthcare Pet Vaccine Product
Table 53. Bayer Healthcare Recent Developments/Updates
Table 54. Vetoquinol S.A Corporation Information
Table 55. Vetoquinol S.A Description and Business Overview
Table 56. Vetoquinol S.A Pet Vaccine Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2017-2022)
Table 57. Vetoquinol S.A Pet Vaccine Product
Table 58. Vetoquinol S.A Recent Developments/Updates
Table 59. Boehringer Ingelheim Corporation Information
Table 60. Boehringer Ingelheim Description and Business Overview
Table 61. Boehringer Ingelheim Pet Vaccine Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2017-2022)
Table 62. Boehringer Ingelheim Pet Vaccine Product
Table 63. Boehringer Ingelheim Recent Developments/Updates
Table 64. Ceva Corporation Information
Table 65. Ceva Description and Business Overview
Table 66. Ceva Pet Vaccine Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2017-2022)
Table 67. Ceva Pet Vaccine Product
Table 68. Ceva Recent Developments/Updates
Table 69. Eli Lilly Corporation Information
Table 70. Eli Lilly Description and Business Overview
Table 71. Eli Lilly Pet Vaccine Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2017-2022)
Table 72. Eli Lilly Pet Vaccine Product
Table 73. Eli Lilly Recent Developments/Updates
Table 74. Heska Co. Corporation Information
Table 75. Heska Co. Description and Business Overview
Table 76. Heska Co. Pet Vaccine Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2017-2022)
Table 77. Heska Co. Pet Vaccine Product
Table 78. Heska Co. Recent Developments/Updates
Table 79. Merck Animal Health Corporation Information
Table 80. Merck Animal Health Description and Business Overview
Table 81. Merck Animal Health Pet Vaccine Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2017-2022)
Table 82. Merck Animal Health Pet Vaccine Product
Table 83. Merck Animal Health Recent Developments/Updates
Table 84. Merial (Sanofi) Corporation Information
Table 85. Merial (Sanofi) Description and Business Overview
Table 86. Merial (Sanofi) Pet Vaccine Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2017-2022)
Table 87. Merial (Sanofi) Pet Vaccine Product
Table 88. Merial (Sanofi) Recent Developments/Updates
Table 89. Virbac Corporation Information
Table 90. Virbac Description and Business Overview
Table 91. Virbac Pet Vaccine Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2017-2022)
Table 92. Virbac Pet Vaccine Product
Table 93. Virbac Recent Developments/Updates
Table 94. Zoetis (Pfizer) Corporation Information
Table 95. Zoetis (Pfizer) Description and Business Overview
Table 96. Zoetis (Pfizer) Pet Vaccine Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2017-2022)
Table 97. Zoetis (Pfizer) Pet Vaccine Product
Table 98. Zoetis (Pfizer) Recent Developments/Updates
Table 99. Production Base and Market Concentration Rate of Raw Material
Table 100. Key Suppliers of Raw Materials
Table 101. Pet Vaccine Distributors List
Table 102. Pet Vaccine Customers List
Table 103. Pet Vaccine Market Trends
Table 104. Pet Vaccine Market Drivers
Table 105. Pet Vaccine Market Challenges
Table 106. Pet Vaccine Market Restraints
Table 107. Global Pet Vaccine Sales Forecast by Type (2023-2028) & (K Doses)
Table 108. Global Pet Vaccine Sales Market Share Forecast by Type (2023-2028)
Table 109. Global Pet Vaccine Revenue Forecast by Type (2023-2028) & (US$ Million)
Table 110. Global Pet Vaccine Revenue Market Share Forecast by Type (2023-2028)
Table 111. Global Pet Vaccine Sales Forecast by Application (2023-2028) & (K Doses)
Table 112. Global Pet Vaccine Sales Market Share Forecast by Application (2023-2028)
Table 113. Global Pet Vaccine Revenue Forecast by Application (2023-2028) & (US$ Million)
Table 114. Global Pet Vaccine Revenue Market Share Forecast by Application (2023-2028)
Table 115. Global Pet Vaccine Sales Forecast by Region (2023-2028) & (K Doses)
Table 116. Global Pet Vaccine Sales Market Share Forecast by Region (2023-2028)
Table 117. Global Pet Vaccine Revenue Forecast by Region (2023-2028) & (US$ Million)
Table 118. Global Pet Vaccine Revenue Market Share Forecast by Region (2023-2028)
Table 119. Research Programs/Design for This Report
Table 120. Key Data Information from Secondary Sources
Table 121. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of Pet Vaccine
Figure 2. Global Pet Vaccine Market Share by Type in 2021 & 2028
Figure 3. Attenuated Live Vaccines Product Picture
Figure 4. Conjugate Vaccines Product Picture
Figure 5. Inactivated Vaccines Product Picture
Figure 6. Subunit Vaccines Product Picture
Figure 7. Toxoid Vaccines Product Picture
Figure 8. DNA Vaccines Product Picture
Figure 9. Recombinant Vaccines Product Picture
Figure 10. Global Pet Vaccine Market Share by Application in 2021 & 2028
Figure 11. Canine
Figure 12. Avian
Figure 13. Feline
Figure 14. Global Pet Vaccine Revenue, (US$ Million), 2017 VS 2021 VS 2028
Figure 15. Global Pet Vaccine Market Size (2017-2028) & (US$ Million)
Figure 16. Global Pet Vaccine Sales (2017-2028) & (K Doses)
Figure 17. Pet Vaccine Sales Share by Manufacturers in 2021
Figure 18. Global Pet Vaccine Revenue Share by Manufacturers in 2021
Figure 19. The Global 5 and 10 Largest Pet Vaccine Players: Market Share by Revenue in 2021
Figure 20. Pet Vaccine Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2017 VS 2021
Figure 21. Global Pet Vaccine Sales Market Share by Region (2017-2022)
Figure 22. Global Pet Vaccine Sales Market Share by Region in 2021
Figure 23. Global Pet Vaccine Revenue Market Share by Region (2017-2022)
Figure 24. Global Pet Vaccine Revenue Market Share by Region in 2021
Figure 25. U.S. Pet Vaccine Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 26. Canada Pet Vaccine Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 27. Germany Pet Vaccine Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 28. France Pet Vaccine Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 29. U.K. Pet Vaccine Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 30. Italy Pet Vaccine Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 31. Russia Pet Vaccine Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 32. China Pet Vaccine Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 33. Japan Pet Vaccine Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 34. South Korea Pet Vaccine Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 35. India Pet Vaccine Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 36. Australia Pet Vaccine Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 37. Taiwan Pet Vaccine Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 38. Indonesia Pet Vaccine Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 39. Thailand Pet Vaccine Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 40. Malaysia Pet Vaccine Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 41. Philippines Pet Vaccine Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 42. Vietnam Pet Vaccine Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 43. Mexico Pet Vaccine Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 44. Brazil Pet Vaccine Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 45. Argentina Pet Vaccine Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 46. Turkey Pet Vaccine Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 47. Saudi Arabia Pet Vaccine Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 48. U.A.E Pet Vaccine Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 49. Sales Market Share of Pet Vaccine by Type (2017-2022)
Figure 50. Manufacturing Cost Structure of Pet Vaccine
Figure 51. Manufacturing Process Analysis of Pet Vaccine
Figure 52. Pet Vaccine Industrial Chain Analysis
Figure 53. Channels of Distribution
Figure 54. Distributors Profiles
Figure 55. Bottom-up and Top-down Approaches for This Report
Figure 56. Data Triangulation
Figure 57. Key Executives Interviewed
Please ask for List of Figures. Request Sample Report
Companies Included in Reports:
Bayer Healthcare Vetoquinol S.A Boehringer Ingelheim Ceva Eli Lilly Heska Co. Merck Animal Health Merial (Sanofi) Virbac Zoetis (Pfizer)